← FDA Drug Approvals (Drugs@FDA)

TRIESENCE

NDA · New Drug Application · Sponsor: ALCON RES · Approved 2007-11-29

Drug application

FDA Application #

NDA022223

Application type

New Drug Application

Brand name

TRIESENCE

Generic name

Triamcinolone Acetonide

Active ingredients

TRIAMCINOLONE ACETONIDE

Dosage form

INJECTABLE

Route

SUSPENSION

Marketing status

Prescription

Sponsor

ALCON RES

First approval

2007-11-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown